|
| 1 |
Preparation and evaluation of microcrystallized cellulose xanthate-metal-oxytetracycline complexes as antibacterial agents with prolonged antibacterial activity
Kong, Hyo-Sik;Lee, You-Na;Lee, Yong-Hyun;Kim, Young-Mi;Jung, Yun-Jin;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.85-91,
|
|
| 2 |
Comparative evaluation of water vapor transmission rate of PVA/Dextran blended hydrogel using European Pharmacopiea and Japanese Industrial Standards method
Choi, Han-Gon;Hwang, Ma-Ro;Oh, Dong-Hoon;Li, Dong-Xun;Kim, Jong-Oh;Lee, Jeong-Hoon;Woo, Jong-Soo;Yong, Chul-Soon;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.93-95,
|
|
| 3 |
Dissolution and Duodenal Permeation Characteristics of Lovastatin from Bile Salt Solid Dispersions
Chun, In-Koo;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.97-106,
|
|
| 4 |
Physicochemical property and skin damage of physical mixture of valsartan and polysorbate 80
Choi, Han-Gon;Sung, Jun-Ho;Oh, Dong-Hoon;Li, Dong-Xun;Cho, Kwan-Hyung;Woo, Jong-Soo;Yong, Chul-Soon;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.107-110,
|
|
| 5 |
Relative Bioavailability and Pharmacokinetics of Newly Designed Cyclosporin A Self-microemulsifying Formulation after Single and Multiple Doses to Dogs
Yang, Su-Geun;Shin, Hee-Jong;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.111-115,
|
|
| 6 |
Crystal Forms of Ziprasidone
Youn, Mi-Hee;Bang, Hyo-Chun;Sohn, Young-Taek;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.117-120,
|
|
| 7 |
Enhanced Topical Delivery of Arbutin using Intense Pulsed Light (IPL)
Choi, Joon-Ho;Chung, Suk-Jae;Shim, Chang-Koo;Kim, Dae-Duk;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.121-125,
|
|
| 8 |
Cytotoxicity Evaluation on Hydrogels for Medical Devices based on the International Organization for Standardization
Kim, Hyun-Ki;Kim, Ye-Tae;Cho, Yang-Ha;Roh, Hye-Won;Kim, Min-A;Kim, So-Yeon;Huh, Kang-Moo;Park, Jeong-Sook;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.127-131,
|
|
| 9 |
Bioequivalence of PirosTM Tablets to ActosTM Tablets (Pioglitazone HCl 15 mg)
Kang, Jong-Min;Lee, Myung-Jae;Seo, Ji-Hyung;Choi, Sang-Jun;Lee, Jin-Sung;Ryu, Ju-Hee;Tak, Sung-Kwon;Yim, Sung-Vin;Hong, Seung-Jae;Lee, Kyung-Tae;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.133-139,
|
|
| 10 |
Bioequivalence of GLUNATE® Tablet to PASTIC® Tablet (nateglinide 90 mg)
Tak, Sung-Kwon;Lee, Jin-Sung;Choi, Sang-Joon;Seo, Ji-Hyung;Lee, Myung-Jae;Kang, Jong-Min;Ryu, Ju-Hee;Hong, Seung-Jae;Yim, Sung-Vin;Lee, Kyung-Tae;
/
The Korean Society of Pharmaceutical Sciences and Technology
, v.39, no.2, pp.141-147,
|
|